Clinical Trial

68Ga-XACP3 PET/CT in Prostate Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to construct a noninvasive approach 68Ga-XACP3 PET/CT to detect tumor lesions in patients with prostate cancer and to compare with 68Ga-PSMA PET/CT.
Trial Details
NCT Number NCT07242014
Lead Sponsor The First Affiliated Hospital of Xiamen University
Conditions Prostate Cancer, PET/CT, ACP3
Enrollment 60 participants
Start Date 2025-09-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-21